References
- FeldmannMBrennanFMMainiRNRheumatoid arthritisCell19968533073108616886
- FeldmannMBrennanFMFoxwellBMMainiRNThe role of TNF alpha and IL-1 in rheumatoid arthritisCur Dir Autoimmun20013188199
- FiresteinGSInvasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?Arthritis Rheum19963911178117908912499
- McInnesIBSchettGCytokines in the pathogenesis of rheumatoid arthritisNature reviews. Nat Rev Immunol200776429442
- BurgerDDayerJMPalmerGGabayCIs IL-1 a good therapeutic target in the treatment of arthritis?Best Pract Res Clin Rheumatol200620587989616980212
- SchettGErosive arthritisArthritis Res Ther20079Suppl 1S217634141
- MichaudKWolfeFComorbidities in rheumatoid arthritisBest Pract Res Clin Rheumatol200721588590617870034
- ZinkAMangerBKaufmannJEvaluation of the RABBIT Risk Score for serious infectionsAnn Rheum Dis20147391673167623740236
- StrangfeldAEveslageMSchneiderMTreatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?Ann Rheum Dis201170111914192021791449
- GabrielSEThe epidemiology of rheumatoid arthritisRheum Dis Clin North Am200127226928111396092
- BartonAWorthingtonJGenetic susceptibility to rheumatoid arthritis: an emerging pictureArthritis Rheum200961101441144619790122
- CarlensCHergensMPGrunewaldJSmoking, use of moist snuff, and risk of chronic inflammatory diseasesAm J Respir Crit Care Med2010181111217122220203245
- MacGregorAJSniederHRigbyASCharacterizing the quantitative genetic contribution to rheumatoid arthritis using data from twinsArthritis Rheum2000431303710643697
- SilmanAJNewmanJMacGregorAJCigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twinsArthritis Rheum19963957327358639169
- LindqvistEEberhardtKBendtzenKHeinegardDSaxneTPrognostic laboratory markers of joint damage in rheumatoid arthritisAnn Rheum Dis200564219620115458956
- BirdPConaghanPEjbjergBThe development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlasAnn Rheum Dis200564Suppl 1i8i1015647422
- BackhausMKamradtTSandrockDArthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imagingArthritis Rheum19994261232124510366117
- ReicheBEOhrndorfSFeistEMesserschmidtJBurmesterGRBackhausMPower doppler ultrasound is useful for prediction of re-therapy with rituximab in rheumatoid arthritisArthritis Care Res (Hoboken)201466220421623925935
- BrennanFMChantryDJacksonAMainiRFeldmannMInhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritisLancet1989286572442472569055
- ElliottMJMainiRNFeldmannMTreatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaArthritis Rheum19933612168116908250987
- LipskyPEvan der HeijdeDMSt ClairEWInfliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupN Engl J Med2000343221594160211096166
- StrangfeldAHierseFRauRRisk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITArthritis Res Ther2010121R520064207
- DreyerLMellemkjaerLAndersenARIncidences of overall and site specific cancers in TNFalpha inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO RegistryAnn Rheum Dis2013721798222945500
- ListingJKekowJMangerBMortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximabAnn Rheum Dis201574241542124291654
- RazaKSaberTPKvienTKTakPPGerlagDMTiming the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trialsAnn Rheum Dis201271121921192322941769
- KyburzDFinckhAThe importance of early treatment for the prognosis of rheumatoid arthritisSwiss Med Wkly2013143w1386524089023
- AllaireSWolfeFNiuJLaValleyMPZhangBReisineSCurrent risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohortArthritis Rheum200961332132819248135
- ShubayevVIPisanicTR2ndJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
- Maier-HauffKUlrichFNestlerDEfficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJ Neurooncol2011103231732420845061
- WangYXHussainSMKrestinGPSuperparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imagingEur Radiol200111112319233111702180
- LodhiaJMandaranoGFerrisNEuPCowellSDevelopment and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRIBiomed Imaging Interv J201062e1221611034
- MandaranoG LJEuPFerrisNJDavidsonRCowellSFDevelopment and use of iron oxide nanoparticles (Part 2): The application of iron oxide contrast agents in MRIBiomed Imaging Interv J201062e13
- YouDGSaravanakumarGSonSDextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imagingCarbohydr Polym20141011225123324299895
- SaraswathyANazeerSSNimiNArumugamSShenoySJJayasreeRSSynthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosisCarbohydr Polym201410176076824299836
- MarkidesHKehoeOMorrisRHEl HajAJWhole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells – a rheumatoid arthritis mouse modelStem Cell Res Ther20134512624406201
- RungeVMSafety of approved MR contrast media for intravenous injectionJ Magn Reson Imaging200012220521310931582
- BulteJWKraitchmanDLIron oxide MR contrast agents for molecular and cellular imagingNMR Biomed200417748449915526347
- EcksteinFCicuttiniFRaynauldJPWatertonJCPeterfyCMagnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessmentOsteoarthritis Cartilage200614Suppl AA46A7516713720
- EcksteinFBursteinDLinkTMQuantitative MRI of cartilage and bone: degenerative changes in osteoarthritisNMR Biomed200619782285417075958
- MacKenzieJD KDImaging of Rheumatoid ArthritisWeissmanBNWImaging of Arthritis and Metabolic Bone DiseaseElsevier Health Sciences2009340364
- KostaPEVoulgariPVZikouAKDrososAAArgyropoulouMIThe usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritisArthritis Res Ther2011133R8421658223
- FilippoDelGrandeAJFAbraham PaduaRTCarrinoJohn AThe Importance of MRI of the Wrist in Patients with Rheumatoid ArthritisSiemens Healthcare2011 Available from: http://usa.healthcare.siemens.com/siemens_hwem-hwem_ssxa_websites-context-root/wcm/idc/siemens_hwem-hwem_ssxa_websites-context-root/wcm/idc/groups/public/@global/@imaging/@mri/documents/download/mdaw/mtu3/~edisp/the_importance_of_mri_of_wrist_in_patients_with_rheumatoid_arthritis_neu-00019770.pdfAccessed January 12, 2015
- KalvaSanjeeva PBlakeMASahaniDushyant VMR contrast agentsApplied Radiology20061827
- SimonGHvon Vopelius-FeldtJWendlandMFMRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs Gd-DTPAJ Magn Reson Imaging200623572072716557494
- WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
- YangCYTaiMFLinCPMechanism of cellular uptake and impact of ferucarbotran on macrophage physiologyPloS One201169e2552421991395
- RaynalIPrigentPPeyramaureSNajidARebuzziCCorotCMacrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10Invest Radiol2004391566314701989
- ChaoYMakaleMKarmaliPPRecognition of Dextran-Superparamagnetic Iron Oxide Nanoparticle Conjugates (Feridex) via Macrophage Scavenger Receptor Charged DomainsBioconjug Chem20122351003100922515422
- LunovOZablotskiiVSyrovetsTModeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophagesBiomaterials201132254755520880574
- SchöpfBChemische und physikalische Nachweismethoden Superparamagnetischer Nanopartikel zur Beurteilung deren Wirkung auf Zellen des Bewegungsapparates In vitro Studie an Osteoblasten, Chondrozyten und Synovialzellen von Schafen [PhD thesis]Vetsuisse-Fakultät Universität Zürich, Pferdeklinik, Musculoskeletal Research Unit, Universität Zürich2004
- SchulzeFDieneltAGeisslerSAmino-polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles are Suitable for Monitoring of Human Mesenchymal Stromal Cells In VivoSmall201410214340435124990430
- Petri-FinkASteitzBFinkaASalaklangJHofmannHEffect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studiesEur J Pharm Biopharm200868112913717881203
- MahmoudiMHofmannHRothen-RutishauserBPetri-FinkAAssessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticlesChem Rev201211242323233822216932
- BlankFGerberPRothen-RutishauserBBiomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cellsNanotoxicology20115460662121231795
- SoenenSJHimmelreichUNuyttenNDe CuyperMCytotoxic effects of iron oxide nanoparticles and implications for safety in cell labellingBiomaterials201132119520520863560
- HoskinsCCuschieriAWangLThe cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanismJ Nanobiotechnology2012101522510488
- CornwellRMSchwertmannUThe iron oxides: structure, properties, reactions, occurrence and uses2nd edWiley-VCH Weinheim2006
- ChastellainMPetriAGuptaARaoKVHofmannHSuperparamagnetic Silica-Iron Oxide Nanocomposites for Application in HyperthermiaAdvanced Engineering Materials200464235241
- ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
- BachmannSSchlichtingUGeistBKidney-specific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa)J Am Soc Nephrol200415489290015034091
- DormannJLFioraniDTroncEMagnetic Relaxation in Fine-Particle SystemsPrigogineIRiceSAAdvances in Chemical PhysicsJohn Wiley & Sons, Inc1997283494
- RodensteinDOStanescuDCDelgustePLiistroGAubert-TulkensGAdaptation to intermittent positive pressure ventilation applied through the nose during day and nightEur Respir J1989254734782668025
- PouliquenDLe JeuneJJPerdrisotRErmiasAJalletPIron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolismMagn Reson Imaging1991932752831881245
- ShvedovaAAKaganVEFadeelBClose encounters of the small kind: adverse effects of man-made materials interfacing with the nanocosmos of biological systemsAnnu Rev Pharmacol Toxicol201050638820055698
- KahruAIvaskAMapping the dawn of nanoecotoxicological researchAcc Chem Res201346382383323148404
- AderemAUnderhillDMMechanisms of phagocytosis in macrophagesAnnu Rev Immunol19991759362310358769
- MullerKSkepperJNPosfaiMEffect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitroBiomaterials20072891629164217178155
- KokkonenHSoderstromIRocklovJHallmansGLejonKRantapaa DahlqvistSUp-regulation of cytokines and chemokines predates the onset of rheumatoid arthritisArthritis Rheum201062238339120112361
- StrehlCFangradtMFearonUGaberTButtgereitFVealeDJHypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability?J Leukoc Biol201495223324124168857
- Monteiro-RiviereNAInmanAOZhangLWLimitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell lineToxicol Appl Pharmacol2009234222223518983864
- SchweigerCHartmannRZhangFParakWJKisselTHRivera GilPQuantification of the internalization patterns of superparamagnetic iron oxide nanoparticles with opposite chargeJ Nanobiotechnology2012102822781560
- JorisFManshianBBPeynshaertKDe SmedtSCBraeckmansKSoenenSJAssessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gapChem Soc Rev201342218339835923877583
- WangTBaiJJiangXNienhausGUCellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistryACS Nano2012621251125922250809
- JonuleitHSchmittESchulerGKnopJEnkAHInduction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cellsJ Exp Med200019291213122211067871
- KatohNSogaFNaraTMasudaKKishimotoSHistamine induces the generation of monocyte-derived dendritic cells that express CD14 but not CD1aJ Invest Dermatol2005125475376016185276
- NovakNBieberTKatohNEngagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cellsJ Immunol2001167279780411441085
- LameijerMATangJNahrendorfMBeelenRHMulderWJMonocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of diseaseExpert Rev Mol Diagn201313656758023895127
- Development of Novel Nanotechnology Based Diagnostic Systems for Rheumatoid Arthritis and Osteoarthritis (NanoDiaRA) www.nanodiara.eu
- GramounACroweLAMauriziLMonitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophagesArthritis Res Ther2014163R13124957862
- MauriziLSakulkhuUCroweLASyntheses of cross-linked polymeric superparamagnetic beads with tunable propertiesRSC Adv20144221114211146